RAFAEL
DÍAZ DE LA GUARDIA GUERRERO
Researcher in the period 1984-2009
University of Zurich
Zúrich, SuizaPublications in collaboration with researchers from University of Zurich (1)
2019
-
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia
Leukemia, Vol. 33, Núm. 7, pp. 1557-1569